Searched for
TREATMENT REGIMEN
Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...- ‘It's a big price tag’: Bryan Johnson explains why international travel affects sleep, cortisol and overall health, tech millionaire says it takes "two weeks to recover"Tech millionaire Bryan Johnson advocates for limiting international travel to once every three months, citing a significant biological cost...
- Haircare startup Xtovia raises Rs 6.9 crore led by V3 VenturesFounded in 2025 by entrepreneur Navneet Misra and Dr Tunga Madhu Babu, who heads research and development and holds a PhD from IIT Madras, ...
- Priyanka Chopra's mother Madhu, a doctor, shares secret behind why she has a 'head full of hair' at 73. The formula is 1400 years oldPriyanka Chopra's mother, Dr. Madhu Chopra, shared her DIY hair mask recipe at 73, featuring coconut oil, fenugreek, chia seeds, cooked ric...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Show of hands: Handcare has become the next big thing in skincare in the West. India is catching upA viral 15-step handcare routine by influencer Victoria Ortega has helped fuel a growing global focus on handcare, turning hands into a new...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- These 5 innocent hair habits may be ruining your scalp healthHair care needs attention after 40. Everyday actions can harm hair, causing thinning and dullness. Experts reveal that dirty hairbrushes sp...
- How Often Should You Really Wash Your Hair in Winter? The Answer May Surprise YouWinter hair washing isn't about a strict schedule, but scalp condition. Dryness may mean fewer washes to avoid irritation, while dandruff m...
- How to Make Rosemary Hair Rinse for Growth and What It May Actually DoWhile social media touts rosemary rinses for hair growth, scientific evidence primarily supports rosemary oil's potential, comparable to mi...
- CPI demands action against 'medical mafia'; calls for ethical healthcare reformsThe Communist Party of India demands action against unethical healthcare practices. They state healthcare is a social obligation, not a pro...
- BPaL regimen can cut time for treatment of drug-resistant TBBPaL is a six-month, alloral, three-drug regimen that is used to treat people with highly drug-resistant forms of TB. It consists of the TB...
- Lancet study finds no benefit for hydroxychloroquine in COVID-19 patientsThe scientists said these drugs should not be used to treat COVID-19 patients outside of clinical trials until results from randomised clin...
- Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
- Johnson and Johnson asked to cut down price of new TB drugTo ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price...
- PM asks CMs to address challenge of TB 'in a mission mode'The PM wrote that the government was committed to eliminating TB by 2015, five years ahead of the Sustainable Development Goals deadline.
- Mylan expands pact with Gilead for hepatitis-C drugDrugmaker Mylan Laboratories Ltd said it has expanded its hepatitis C licensing agreement with Gilead Sciences, a US-based biopharma compan...
- TB treatment could be shortened, show trialsThe effectiveness of the four-month regimen was proved on the basis of recurrence levels, number of patients testing negative in sputum sme...
Load More
